Immune tolerance induction in patients with severe hemophilia A with inhibitors.

Journal: Blood research
Published Date: Dec 21, 2015

Abstract

BACKGROUND: Inhibitory antibodies to factor VIII (FVIII) are an important complication when managing patients with hemophilia A. Immune tolerance induction (ITI) has been regarded as a useful method for eradicating inhibitors. We report the results of a retrospective study in Korean patients with hemophilia A who underwent ITI.

Authors

  • Ji Eun Ryu
    College of Pharmacy, Chung-Ang University, Seoul 06974, Republic of Korea.
  • Young Shil Park
    Department of Pediatrics, Kyung Hee University Hospital at Gangdong, Kyung Hee University School of Medicine, Seoul, Korea.
  • Ki Young Yoo
    Korea Hemophilia Foundation, Seoul, Korea.
  • Kyoo Duck Lee
    Health Insurance Review & Assessment Service, Seoul, Korea.
  • Yong-Mook Choi
    Korea Hemophilia Foundation, Seoul, Korea.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals